𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Monoclonal antibodies in cancer therapy

✍ Scribed by Gert Riethmüller; Elena Schneider-Gädicke; Judith P. Johnson

Publisher
Elsevier Science
Year
1993
Tongue
English
Weight
1022 KB
Volume
5
Category
Article
ISSN
0952-7915

No coin nor oath required. For personal study only.

✦ Synopsis

A review of the clinical trials of antibody based cancer therapies reveals that this approach can, in rare cases, induce complete remissions in individual patients with cancer. Since these trials have usually involved patients with large tumor masses, tumor cell inaccessibility is probably a major reason for the prevailing failures. Minimal residual disease, the stage when tumor cells are few and dispersed, should therefore be a more promising target for therapeutic antibodies. This hypothesis is supported by a prospective randomized trial on patients with resected Dukes C colorectal carcinoma that resulted in increased survival and prolonged recurrence-free intervals. Thus, in addition to strategies designed to produce more effective, human-derived reagents, efforts need to be concentrated on directing passive antibody therapy towards the appropriate target.

📜 SIMILAR VOLUMES

Monoclonal antibodies in the study and t
Monoclonal antibodies in the study and therapy of hematopoietic cancers
✍ Dana C Matthews; Franklin O Smith; Irwin D Bernstein 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 904 KB

Recent advances utilizing monoclonal antibodies to phenotype acute leukemias have revealed no prognostic significance of the expression of lymphoid-associated antigens by acute myeloid leukemia blasts and conflicting results regarding 'biphenotypic' acute myeloid leukemia. Several studies treating p

Infectious complications of monoclonal a
Infectious complications of monoclonal antibodies used in cancer therapy : A systematic review of the evidence from randomized controlled trials
✍ Petros I. Rafailidis; Ourania K. Kakisi; Konstantinos Vardakas; Matthew E. Falag 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

## Abstract The introduction of monoclonal antibodies (MoAbs) into the treatment of cancer has led to improvements in patient survival. However, to the authors' knowledge, little attention has been paid to the infectious complications associated with their use. The authors performed a systematic re